Shineway Pharmaceutical distinguished itself from over 3,000 enterprises with sales over RMB100 million and was listed among the "2005 Top 100 Growth Enterprises of China".   Shu Xie Ning injection was awarded Certificate of State Protected Chinese Medicine.     During the "2005 China's Innovation and Brand Conference" organized by the Economic Daily, Shineway Pharmaceutical was awarded "Made in China - The Best Potential Brand Enterprise of the Industry".   Shineway Pharmaceutical's advanced technology integration and commercialisation of hitech automated production process for Chinese medicines was honoured as "Model Project of Hi-Tech Production of the Country".   Shujin Tongluo granule was awarded Certificate of New Medicine.   The research project of "Zhikeping soft capsule" conducted by Shineway Pharmaceutical under The National Advanced Technology and Development Scheme (863 Scheme) was approved by the State.   Shineway Pharmaceutical was awarded "The Best 10 Employers in the Pharmaceutical Industry" at the Fourth Annual Human Resources Awards ceremony.     Six products, including Qing Kai Ling injection, Qing Kai Ling soft capsule, Huang Qi injection and Shen Mai injection, were included in the "Human Transmitted Avian Flu Guideline 2005" issued by the Ministry of Health.   According to the enterprise information center of the National Bureau of Statistics, Shineway Pharmaceutical was listed among the year 2004 top ten most profitable enterprises of Chinese medicine manufacturing industry.     Zhikeping Jiangzhi Tongluo soft capsule and another injection product were awarded "Special Golden Award of Selected Applications of Chinese Patents in the Past 20 Years".   Danggui soft capsule and Shujin Tongluo granule were awarded "Golden Award of Selected Applications of Chinese Patents in the Past 20 Years".     Li Zhenjiang, Chairman of the Board, was elected as Vice Chairman of PRC Association of Chinese Medicine.   Paediatric Qingfei Huatan granule was rewarded a renewed Certificates of State Protected Chinese Medicine.     Zhikeping Jiangzhi Tongluo soft capsule was listed in State Key New Product Plan and was awarded the Certificate of State Key New Product co-issued by Ministry of Science and Technology, State Ministry of Commerce, State General Bureau of Environment Protection and State Administration of Quality & Technology.     Guan Xin Ning injection was awarded Certificate of State Protected Chinese Medicine.     Li Zhenjiang, Chairman of the Board, was elected National Model Worker.   Xue Sai Tong dropping pill was awarded the Certificate of New Medicine.     Four products, namely Wu Fu Xing Nao Qing soft capsule, Huo Xiang Zheng Qi soft capsule, Qing Kai Ling soft capsule and Zhikeping Jiangzhi Tongluo soft capsule, were awarded Hebei Province High-Tech Product Certificates.     Shineway Pharmaceutical was ranked among the top 200 companies listed on Stock Exchange in terms of market capitalization and its shares became one of the Hang Seng Composite Index constituent stocks.     Phase 2 of the Chinese medicine extraction workshop commenced operation, which doubles the extraction capabilities. Its capacity and technology are believed to be the topmost in the country.